News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Ackman: Allergan CEO has conflict of interest on takeover offer

Started by riky, May 20, 2014, 09:00:20 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Ackman: Allergan CEO has conflict of interest on takeover offer

<p><a href="http://news.yahoo.com/activist-ackman-says-allergan-ceo-conflict-over-letting-131813295--sector.html"><img src="http://l.yimg.com/bt/api/res/1.2/yrJUO.bvI3Z8l8l6SLS_TQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-05-19T222054Z_3_CBREA4I10YL00_RTROPTP_2_FUNDS-IRASOHN-ACKMA.JPG" width="130" height="86" alt="Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks at the Sohn Investment Conference in New York" align="left" title="Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks at the Sohn Investment Conference in New York" border="0" /></a>Activist investor William Ackman said on Monday that Allergan Inc's chief executive has a &quot;disabling&quot; conflict of interest because a takeover of his company by Valeant Pharmaceuticals International Inc would likely mean the loss of his job. Ackman and Montreal-based Valeant launched a $47 billion takeover of the company on April 22, but Allergan rejected the offer on May 12 and has not budged since. Allergan Chief Executive David Pyott is urging shareholders to let the company stand alone. Ackman, who controls a nearly 10 percent stake in Allergan as the head of Pershing Square Capital Management, criticized Allergan's position in a May 19 letter to its lead director, Michael Gallagher.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login